ATAD3B is a human embryonic stem cell‐specific mitochondrial protein, which has been used as the prognostic biomarker for hepatocellular carcinoma[27] and BLCA.[28] Collectively, these findings suggested that RNA editing may be an important determinant of mediating anticancer drug response. The gene discussed is ATAD3B; the disease is bladder transitional cell carcinoma.